Elkar Solution for internal administration, with a measuring spoon, 50 ml

Elkar rr d / int.

taking 300mg / ml vial.

50ml with measuring spoon

Name ENG

ELCAR

Clinical and pharmacological group

A drug that improves metabolism and energy supply of tissues

ATX code

Levocarnitine

Dosage

300mg / ml x 50ml

Structure

1 ml of oral solution contains: levocarnitine (carniphite) 300 mg.

Excipients: citric acid monohydrate 1.2 mg, methyl parahydroxybenzoate 0.5 mg, propyl parahydroxybenzoate 0.2 mg, purified water up to 1 ml.

Indications

The drug is used as part of complex therapy. intense physical activity and psychoemotional stress: to improve performance, endurance, reduce fatigue, including in the elderly during the period of rehabilitation after diseases and surgical interventions, injuries, including, to accelerate tissue regeneration complex therapy of chronic gastritis and chronic pancreatitis with reduced secretory function complex therapy of skin diseases (psoriasis, seborrheic eczema, focal scleroderma and discoid lupus erythematosus) mild hyperthyroidism neurological manifestations in vascular, toxic and traumatic brain damage anorexia nervosa syndrome diseases accompanied by a lack of carnitine or its increased loss (myopathy, cardiomyopathy,mitochondrial diseases, hereditary diseases with concomitant mitochondrial insufficiency) to compensate for its deficiency as part of complex therapy in pediatric practice (treatment of children under 3 years of age under the supervision of a doctor): when nursing premature infants, newborns who have suffered a birth injury or asphyxiation children with a sluggish sucking reflex and low weight gain decreased muscle tone, with insufficient development of motor and mental functions, as well as with the aim of preventing these disorders in children of the risk group" with growth retardation and underweight in children and adolescents under 16 years of age. in adults in sports medicine and during intense training (during the training process when working out aerobic performance): to improve speed-strength indicators and coordination of movements,to increase muscle mass and reduce body fat mass, to prevent post-workout syndrome (accelerate recovery processes after physical exertion), with traumatic injuries in order to accelerate muscle regeneration.

INN / Active ingredient

Levocarnitine

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 3 years

after opening - 2 months (at a temperature of 2-8 degrees)

Specifications

Category

Preparations for the gastrointestinal tract

Scope of the drug

Gastrointestinal tract

,

Dermatology

,

Metabolism

,

Vitamins

Release form

Solution

Manufacturer country

Russia

Package quantity, pcs

one

Scope of application

Dermatology

,

Gastroenterology

,

Pediatrics

Minimum age from

From birth

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Volume, ml.

50 ml

Brand name

Peak Pharma

Components

measuring spoon

The amount of the dosage form in the primary package

50 ml

Primary packaging type

Bottle

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

Metabolic agent

Anatomical and therapeutic characteristics

A16AA01 Levocarnitine

Dosage form

Oral solution

Packaging

Box

Dosage (volume) of the substance in the preparation

1 ml: levocarnitine 300 mg

Expiration date in days

1095

The target audience

Children

Package weight, g

one hundred

Mode of application

:

The drug is used as part of complex therapy. Inside 30 minutes before meals, additionally diluted with liquid. < br> With prolonged physical and psycho-emotional stress: from 0.75 g (1/2 measuring spoon or 2.5 ml) 3 times a day to 2.25 g (1.5 measuring spoon or 7.5 ml) 2- 3 times a day. < br> With anorexia nervosa, as well as during the period of rehabilitation after illnesses and surgical interventions and injuries: 1.5 g (1 measuring spoon or 5 ml) 2 times a day. The course of treatment is within 1-2 months. < br> In the complex therapy of chronic gastritis and chronic pancreatitis with reduced secretory function: 0.375 g (1/4 measuring spoon or 1.25 ml) 2 times a day. The course of treatment is within 1-1.5 months. < br> For the treatment of skin diseases: 0.75 g each (1/2 measuring spoon or 2.5 ml). The course of treatment is within 2-4 weeks. < br> With mild hyperthyroidism: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break, or is prescribed for 3 months without a break. < br> For vascular, toxic and traumatic brain lesions: 0.75 g (1/2 measuring spoon or 2.5 ml) per day. The course of treatment is within 3-5 days. If necessary, a second course is prescribed after 12-14 days. < br> For diseases accompanied by a lack of carnitine (primary and secondary carnitine deficiency): up to 50-100 mg / kg (2-5 drops / kg) body weight with a frequency of taking 2-3 times a day. The course of treatment is within 3-4 months. < br> Children are prescribed in the form of an additive to sweet dishes (jelly, compote, juices): for children under 3 years of age, the dose is determined by the attending physician from 3 to 6 years old - in a single dose of 0.1 g (5 drops) 2-3 times a day,in a daily dose of 0.2-0.3 g (11-16 drops). The course of treatment is 1 month children from 6 to 12 years old are prescribed in a single dose of 0.2-0.3 g (11-16 drops) 2-3 times a day, in a daily dose of 0.4-0.9 g (22-48 drops). The course of treatment is at least 1 month. < br> With growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break, or is prescribed for 3 months without a break. < br> In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5 -7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.in a daily dose of 0.4-0.9 g (22-48 drops). The course of treatment is at least 1 month. < br> With growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break, or is prescribed for 3 months without a break. < br> In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5 -7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.in a daily dose of 0.4-0.9 g (22-48 drops). The course of treatment is at least 1 month. < br> With growth retardation: 0.25 g (13 drops) 2-3 times a day. The course of treatment is 20 days. The course of treatment is repeated after a 1-2 month break, or is prescribed for 3 months without a break. < br> In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5 -7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5-7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.In sports medicine and with intensive training: 2.5 g 1-3 times a day (daily dose 2.5-7.5 g). In the case of medicinal use - 70-100 mg / kg / day (5-7.5 g / day). Reception courses: 3-4 weeks in the pre-competition period. During the training process - up to 6-8 weeks.

Information on technical characteristics, delivery set, country of manufacture "